CAMBRIDGE, Mass., Nov. 10, 2021 /PRNewswire/ -- Theseus
Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus"), a
biopharmaceutical company focused on improving the lives of cancer
patients through the discovery, development and commercialization
of transformative targeted therapies, today announced that
Tim Clackson, Ph.D., President and
Chief Executive Officer of Theseus, will participate in a virtual
fireside chat for the 12th Annual Jefferies London Healthcare
Conference, taking place November 16-19,
2021.
Presentation Details:
Event: Jefferies
London Healthcare Conference
Date / Time: Pre-record available beginning
Thursday, November 18th at
8:00am GMT / 3:00am ET and available through Friday, November 19th at 5:00pm GMT / 12:00pm
ET
Format: Fireside Chat
A webcast link from the Jefferies fireside chat will be
accessible under "Events" in the "Investors & Media" section of
the Company's website at www.theseusrx.com. Following the
event, archived webcasts will also be available on the Jefferies
website for 30 days.
About Theseus Pharmaceuticals, Inc.
Theseus is a
biopharmaceutical company focused on improving the lives of cancer
patients through the discovery, development and commercialization
of transformative targeted therapies. Theseus is developing
next-generation tyrosine kinase inhibitors (TKIs): "pan-variant"
targeted therapies that address all major drug resistance
mutations. Theseus' lead product candidate, THE-630, is a
pan-variant KIT inhibitor for the treatment of patients with
advanced gastrointestinal stromal tumors (GIST), whose cancer has
developed resistance to earlier lines of kinase inhibitor therapy.
Theseus is also developing a fourth-generation, selective epidermal
growth factor receptor (EGFR) inhibitor for C797S-mediated
resistance to first- or later-line osimertinib treatment in
patients with non-small cell lung cancer (NSCLC). For more
information, visit www.theseusrx.com.
Media Contact
Amy Jobe,
Ph.D.
LifeSci Communications
315-879-8192
ajobe@lifescicomms.com
Investor Contact
Christen
Baglaneas
Theseus Pharmaceuticals
857-706-4993
christen.baglaneas@theseusrx.com
View original
content:https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-to-participate-virtually-in-jefferies-london-healthcare-conference-301420559.html
SOURCE Theseus Pharmaceuticals